Phil Knight, Co-Founder of Nike, is a philanthropist whose sustained investments have had a transformative impact on cancer research, precision oncology, and academic health systems. Together with his wife, Penny Knight, he has been one of the most influential benefactors in modern cancer philanthropy, particularly through their long-standing partnership with the Oregon Health & Science University (OHSU) Knight Cancer Institute.
In 2025, the Knights announced a record-breaking $2 billion commitment to the Knight Cancer Institute—one of the largest single donations ever made to a cancer center worldwide. This landmark investment builds on their earlier support, including the $1 billion Knight Cancer Challenge, which catalyzed one of the world’s first large-scale programs dedicated to early cancer detection and accelerated advances in targeted and precision therapies. Their philanthropy has played a central role in establishing OHSU as a global leader in oncology research, diagnostics, and patient care.
The 100 Most Influential People in Oncology in 2025 recognizes the changemakers in cancer care who have helped shape current practice in oncology and continue to drive innovation and research towards better outcomes, advocacy, philanthropy, leadership and education. For the many deserving individuals not mentioned in this list, we will continue to acknowledge, honor and elevate your voices in our daily publications from across the world.
See the full list of The 100 Influential People in Oncology in 2025 and stay tuned for the results of special category nominations to be announced.
